CVS Health Corporation (CVS) 재무상태표
NYSE · Healthcare · Medical - Healthcare Plans · 직원 259,500명 · CEO J. David Joyner
- 주가
- $90.25 -0.09%
- 시가총액
- $1150억
- 기업가치
- $1800억
- 최근 실적
- Q2 '26 2026-08-05 제출
- 다음 실적
- 2026-11-04 EPS 추정 $1.65
CVS Health Corporation (CVS)의 Q2 '26말 현금 및 단기투자는 $140억, 리스 포함 차입금은 $763억입니다. 자산총계 $2540억, 부채총계 $1740억, 주주지분 $797억.
재무상태표
| 재무상태표 | 추세 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||||
| 현금 및 현금성자산 | $130억 | $82억 | $98억 | $125억 | $68.8억 | $85.9억 | $101억 | $118억 | $91.6억 | $85.1억 | $95.4억 | $113억 | |
| 단기투자 | $31.5억 | $32.6억 | $32.9억 | $37.6억 | $28.1억 | $24.1억 | $25.8억 | $23.9억 | $21.3억 | $21.5억 | $22.6억 | $26.3억 | |
| 매출채권 | $329억 | $352억 | $322억 | $324억 | $362억 | $365억 | $396억 | $407억 | $439억 | $398억 | $410억 | $403억 | |
| 재고자산 | $180억 | $180억 | $163억 | $161억 | $176억 | $181억 | $174억 | $174억 | $190억 | $192억 | $178억 | $176억 | |
| 기타 유동자산 | $30.7억 | $31.5억 | $58.2억 | $52.4억 | $38.4억 | $30.8억 | $35.3억 | $33.4억 | $30억 | $50.3억 | $42.5억 | $34.6억 | |
| 유동자산 | $701억 | $679억 | $675억 | $700억 | $673억 | $686억 | $732억 | $756억 | $771억 | $747억 | $748억 | $753억 | |
| 유형자산(순액) | $306억 | $304억 | $301억 | $299억 | $290억 | $289억 | $286억 | $283억 | $281억 | $281억 | $278억 | $276억 | |
| 장기투자 | $217억 | $230억 | $241억 | $250억 | $289억 | $289억 | $289억 | $301억 | $318억 | $329억 | $324억 | $332억 | |
| 영업권 | $913억 | $913억 | $913억 | $913억 | $913억 | $913억 | $912억 | $912억 | $855억 | $855억 | $855억 | $855억 | |
| 무형자산 | $296억 | $292억 | $288억 | $283억 | $278억 | $273억 | $266억 | $262억 | $260억 | $255억 | $251억 | $246억 | |
| 이연법인세자산 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $75.3억 | $0 | $0 | |
| 기타 비유동자산 | $80.3억 | $79.1억 | $80.7억 | $79.9억 | $81억 | $81억 | $71.6억 | $68.8억 | $69억 | $69.1억 | $74.2억 | $74.3억 | |
| 비유동자산 | $1810억 | $1820억 | $1820억 | $1830억 | $1850억 | $1850억 | $1820억 | $1830억 | $1780억 | $1860억 | $1780억 | $1780억 | |
| 자산총계 | $2510억 | $2500억 | $2500억 | $2520억 | $2520억 | $2530억 | $2560억 | $2580억 | $2550억 | $2610억 | $2530억 | $2540억 | |
| 부채 | |||||||||||||
| 매입채무 | $149억 | $149억 | $137억 | $144억 | $157억 | $159억 | $165억 | $173억 | $609억 | $594억 | $169억 | $172억 | |
| 미지급비용 | $226억 | $222억 | $224억 | $212억 | $202억 | $208억 | $224억 | $231억 | $0 | $2200만 | $223억 | $225억 | |
| 단기차입금 | $21.3억 | $29.7억 | $64.5억 | $37.3억 | $57.1억 | $57.4억 | $56.7억 | $92억 | $72.4억 | $58.1억 | $25.8억 | $19.6억 | |
| 이연수익 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5800만 | $6200만 | $0 | $900만 | |
| 기타 유동부채 | $61.9억 | $24.7억 | $22.4억 | $20.9억 | $19.6억 | $11.8억 | $15.7억 | $10.9억 | $245억 | $234억 | $10.8억 | $173억 | |
| 유동부채 | $816억 | $792억 | $833억 | $814억 | $846억 | $846억 | $890억 | $942억 | $927억 | $887억 | $864억 | $870억 | |
| 장기차입금 | $598억 | $586억 | $577억 | $626억 | $598억 | $605억 | $590억 | $573억 | $605억 | $729억 | $605억 | $595억 | |
| 리스부채(비유동) | $164억 | $160억 | $157억 | $155억 | $153억 | $149억 | $146억 | $143억 | $140억 | $149억 | $133억 | $130억 | |
| 이연법인세부채 | $42.5억 | $43.1억 | $41.8억 | $40.5억 | $36.3억 | $38.1억 | $36.6억 | $36억 | $35.5억 | $114억 | $37.7억 | $37.7억 | |
| 기타 비유동부채 | $148억 | $149억 | $147억 | $138억 | $140억 | $136억 | $122억 | $114억 | $115억 | -$21.6억 | $113억 | $106억 | |
| 비유동부채 | $952억 | $939억 | $923억 | $960억 | $927억 | $929억 | $895억 | $866억 | $895억 | $970억 | $889억 | $868억 | |
| 부채총계 | $1770억 | $1730억 | $1760억 | $1770억 | $1770억 | $1770억 | $1780억 | $1810억 | $1820억 | $1860억 | $1750억 | $1740억 | |
| 자본 | |||||||||||||
| 보통주 및 주식발행초과금 | $488억 | $490억 | $492억 | $494억 | $495억 | $497억 | $498억 | $1800만 | $502억 | $1800만 | $507억 | $1800만 | |
| 이익잉여금 | $603억 | $616억 | $619억 | $628억 | $620억 | $628억 | $638억 | $639억 | $591억 | $612억 | $633억 | $654억 | |
| 기타포괄손익누계액 | -$10억 | -$2.97억 | -$3.41억 | -$3.19억 | $2.09억 | -$1.2억 | $5900만 | $2.72억 | $4.16억 | $4.06억 | $2.01억 | $1.88억 | |
| 주주지분 | $743억 | $765억 | $740억 | $749억 | $749억 | $756억 | $769억 | $774억 | $729억 | $752억 | $775억 | $797억 | |
| 부채(차입) | |||||||||||||
| 총차입금(리스 포함) | $801억 | $794억 | $818억 | $838억 | $827억 | $829억 | $812억 | $827억 | $818억 | $936억 | $783억 | $763억 | |
| 순차입금(차입금 - 현금) | $671억 | $712억 | $720억 | $713억 | $758억 | $743억 | $711억 | $709억 | $727억 | $851억 | $688억 | $650억 | |
| 재무상태표 | 추세 | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 자산 | |||||||||||
| 현금 및 현금성자산 | $33.7억 | $17억 | $40.6억 | $56.8억 | $78.5억 | $94.1억 | $129억 | $82억 | $85.9억 | $85.1억 | |
| 단기투자 | $8700만 | $1.11억 | $25.2억 | $23.7억 | $30억 | $31.2억 | $27.8억 | $32.6억 | $24.1억 | $21.5억 | |
| 매출채권 | $122억 | $132억 | $176억 | $196억 | $217억 | $244억 | $273억 | $352억 | $365억 | $398억 | |
| 재고자산 | $148억 | $153억 | $165억 | $175억 | $185억 | $178억 | $191억 | $180억 | $181억 | $192억 | |
| 기타 유동자산 | $6.6억 | $9.45억 | $45.8억 | $51.1억 | $52.8억 | $52.9억 | $35.4억 | $31.5억 | $30.8억 | $50.3억 | |
| 유동자산 | $310억 | $312억 | $452억 | $503억 | $564억 | $600억 | $656억 | $679억 | $686억 | $747억 | |
| 유형자산(순액) | $102억 | $103억 | $113억 | $329억 | $333억 | $320억 | $307억 | $304억 | $289억 | $281억 | |
| 장기투자 | $0 | $1.12억 | $157억 | $173억 | $208억 | $230억 | $211억 | $230억 | $289억 | $329억 | |
| 영업권 | $382억 | $385억 | $787억 | $797억 | $796억 | $791억 | $782억 | $913억 | $913억 | $855억 | |
| 무형자산 | $135억 | $136억 | $365억 | $331억 | $311억 | $290억 | $248억 | $292억 | $273억 | $255억 | |
| 이연법인세자산 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $75.3억 | |
| 기타 비유동자산 | $14.9억 | $14.2억 | $89.3억 | $90.6억 | $95.1억 | $98억 | $78.5억 | $79.1억 | $81억 | $69.1억 | |
| 비유동자산 | $634억 | $639억 | $1510억 | $1720억 | $1740억 | $1730억 | $1630억 | $1820억 | $1850억 | $1860억 | |
| 자산총계 | $945억 | $951억 | $1960억 | $2220억 | $2310억 | $2330억 | $2280억 | $2500억 | $2530억 | $2610억 | |
| 부채 | |||||||||||
| 매입채무 | $79.5억 | $88.6억 | $89.3억 | $105억 | $111억 | $125억 | $148억 | $149억 | $159억 | $594억 | |
| 미지급비용 | $69.4억 | $65.8억 | $107억 | $121억 | $142억 | $177억 | $187억 | $222억 | $208억 | $2200만 | |
| 단기차입금 | $19.2억 | $48.2억 | $19.9억 | $37.8억 | $54.4억 | $42.1억 | $17.8억 | $29.7억 | $57.4억 | $58.1억 | |
| 미지급세금 | $33.2억 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| 이연수익 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6200만 | |
| 기타 유동부채 | $0 | $2300만 | $48.8억 | $48.2억 | $58.3억 | $56억 | $28.2억 | $24.7억 | $11.8억 | $234억 | |
| 유동부채 | $263억 | $306억 | $440억 | $533억 | $620억 | $678억 | $694억 | $792억 | $846억 | $887억 | |
| 장기차입금 | $256억 | $222억 | $714억 | $647억 | $592억 | $520억 | $505억 | $586억 | $605억 | $729억 | |
| 리스부채(비유동) | $0 | $0 | $0 | $189억 | $188억 | $182억 | $168억 | $160억 | $149억 | $149억 | |
| 이연법인세부채 | $42.1억 | $30억 | $76.8억 | $72.9억 | $67.9억 | $62.7억 | $40.2억 | $43.1억 | $38.1억 | $114억 | |
| 기타 비유동부채 | $15.5억 | $16.1억 | $148억 | $141억 | $142억 | $134억 | $158억 | $149억 | $136억 | -$21.6억 | |
| 비유동부채 | $314억 | $268억 | $939억 | $1050억 | $990억 | $898억 | $871억 | $939억 | $929억 | $970억 | |
| 부채총계 | $576억 | $574억 | $1380억 | $1580억 | $1610억 | $1580억 | $1570억 | $1730억 | $1770억 | $1860억 | |
| 자본 | |||||||||||
| 보통주 및 주식발행초과금 | $1700만 | $321억 | $454억 | $460억 | $465억 | $474억 | $482억 | $490억 | $1800만 | $1800만 | |
| 이익잉여금 | $390억 | $436억 | $409억 | $451억 | $496억 | $549억 | $564억 | $616억 | $628억 | $612억 | |
| 기타포괄손익누계액 | -$3.05억 | -$1.65억 | $1.02억 | $10.2억 | $14.1억 | $9.65억 | -$12.6억 | -$2.97억 | -$1.2억 | $4.06억 | |
| 주주지분 | $368억 | $377억 | $582억 | $639억 | $694억 | $751억 | $715억 | $765억 | $756억 | $752억 | |
| 부채(차입) | |||||||||||
| 총차입금(리스 포함) | $275억 | $270억 | $734억 | $890억 | $850억 | $760억 | $707억 | $794억 | $829억 | $936억 | |
| 순차입금(차입금 - 현금) | $242억 | $253억 | $694억 | $833억 | $772억 | $666억 | $578억 | $712억 | $743억 | $851억 | |
Financial Modeling Prep이 기업의 제출 서류를 표준화한 데이터입니다. 지출과 비용은 제공처가 보고한 부호를 그대로 유지합니다. 기간에 마우스를 올리면 종료일이 표시됩니다. 금액 단위는 USD.
현금, 투자, 차입금
분기말다른 재무제표
출처
재무제표, 부문 매출, 지표, 추정치: Financial Modeling Prep. 부문별 이익과 전체 보고 항목: SEC EDGAR(XBRL). 참조한 제출 서류: 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30, 10-Q 2024-06-30
데이터 기준일 2026-11-01